亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Risk of Recurrence after Surgical Resection for Adenocarcinoma Arising from Intraductal Papillary Mucinous Neoplasia (IPMN) with Patterns of Distribution and Treatment

医学 比例危险模型 腺癌 队列 内科学 对数秩检验 胃肠病学 外科 生存分析 阶段(地层学) 癌症 古生物学 生物
作者
James Lucocq,Jake Hawkyard,Francis P. Robertson,Beate Haugk,Jonathan Lye,Daniel Parkinson,Steve White,Omar Mownah,Yoh Zen,Krishna Menon,Takaaki Furukawa,Yosuke Inoue,Yuki Hirose,Naoki Sasahira,Michael Feretis,Anita Balakrishnan,Piotr Zelga,Carlo Ceresa,Brian R Davidson,Rupaly Pandé
出处
期刊:Annals of Surgery [Lippincott Williams & Wilkins]
被引量:9
标识
DOI:10.1097/sla.0000000000006144
摘要

Objective: This international multicentre cohort study aims to identify recurrence patterns and treatment of first and second recurrence in a large cohort of patients after pancreatic resection for adenocarcinoma arising from IPMN. Summary Background Data: Recurrence patterns and treatment of recurrence post resection of adenocarcinoma arising from IPMN are poorly explored. Method: Patients undergoing pancreatic resection for adenocarcinoma from IPMN between January 2010 to December 2020 at 18 pancreatic centres were identified. Survival analysis was performed by the Kaplan-Meier log rank test and multivariable logistic regression by Cox-Proportional Hazards modelling. Endpoints were recurrence (time-to, location, and pattern of recurrence) and survival (overall survival and adjusted for treatment provided). Results: Four hundred and fifty-nine patients were included (median, 70 y; IQR, 64-76; male, 54 percent) with a median follow-up of 26.3 months (IQR, 13.0-48.1 mo). Recurrence occurred in 209 patients (45.5 percent; median time to recurrence, 32.8 months, early recurrence [within 1 y], 23.2 percent). Eighty-three (18.1 percent) patients experienced a local regional recurrence and 164 (35.7 percent) patients experienced distant recurrence. Adjuvant chemotherapy was not associated with reduction in recurrence (HR 1.09; P =0.669) One hundred and twenty patients with recurrence received further treatment. The median survival with and without additional treatment was 27.0 and 14.6 months ( P <0.001), with no significant difference between treatment modalities. There was no significant difference in survival between location of recurrence ( P =0.401). Conclusion: Recurrence after pancreatic resection for adenocarcinoma arising from IPMN is frequent with a quarter of patients recurring within 12 months. Treatment of recurrence is associated with improved overall survival and should be considered.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Marshall完成签到 ,获得积分10
18秒前
范振杰完成签到,获得积分10
43秒前
52秒前
Hayat应助科研通管家采纳,获得10
59秒前
赘婿应助科研通管家采纳,获得30
59秒前
英俊的铭应助科研通管家采纳,获得10
59秒前
1分钟前
libob关注了科研通微信公众号
2分钟前
852应助libob采纳,获得10
2分钟前
大模型应助科研通管家采纳,获得10
3分钟前
3分钟前
LuoYixiang发布了新的文献求助10
3分钟前
牛八先生完成签到,获得积分10
3分钟前
LuoYixiang完成签到,获得积分10
3分钟前
3分钟前
CCC1230发布了新的文献求助10
3分钟前
3分钟前
4分钟前
libob发布了新的文献求助10
4分钟前
Hello应助CCC1230采纳,获得10
4分钟前
CCC1230完成签到,获得积分10
4分钟前
汉堡包应助Pengzhuhuai采纳,获得10
4分钟前
完美世界应助失眠奥特曼采纳,获得10
4分钟前
Akim应助科研通管家采纳,获得10
4分钟前
Lucas应助科研通管家采纳,获得10
4分钟前
Lucas应助科研通管家采纳,获得10
4分钟前
5分钟前
5分钟前
GuiSHda完成签到,获得积分10
5分钟前
5分钟前
Pengzhuhuai发布了新的文献求助10
5分钟前
Pengzhuhuai完成签到,获得积分10
6分钟前
Augustines完成签到,获得积分10
6分钟前
6分钟前
6分钟前
929发布了新的文献求助10
6分钟前
6分钟前
6分钟前
6分钟前
6分钟前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Cognitive Neuroscience: The Biology of the Mind 1000
Technical Brochure TB 814: LPIT applications in HV gas insulated switchgear 1000
Immigrant Incorporation in East Asian Democracies 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
A Preliminary Study on Correlation Between Independent Components of Facial Thermal Images and Subjective Assessment of Chronic Stress 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3965717
求助须知:如何正确求助?哪些是违规求助? 3510950
关于积分的说明 11155657
捐赠科研通 3245410
什么是DOI,文献DOI怎么找? 1792876
邀请新用户注册赠送积分活动 874181
科研通“疑难数据库(出版商)”最低求助积分说明 804216